GLOBAL TRAVELER'S DIARRHEA THERAPEUTICS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Jul 2019 116

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Scope of the Report:
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.
The worldwide market for Traveler's Diarrhea Therapeutics is expected to grow at a CAGR of roughly 7.1% over the next five years, will reach 890 million US$ in 2024, from 630 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Traveler's Diarrhea Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Salix Pharmaceuticals
- P&G
- Johnson & Johnson
- Otsuka Pharma
- Valneva
- Shanghai United Cell
- PaxVax
- Livzon
- Immuron

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Immunization
- Non-antibiotic Agents
- Antibiotics
- Anti-Motility Agents
- Other

Market Segment by Applications, can be divided into
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea

There are 15 Chapters to deeply display the global Traveler's Diarrhea Therapeutics market.
Chapter 1, to describe Traveler's Diarrhea Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Traveler's Diarrhea Therapeutics, with sales, revenue, and price of Traveler's Diarrhea Therapeutics, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Traveler's Diarrhea Therapeutics, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Traveler's Diarrhea Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Mar 20)

Market Overview The global Artesunate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Plant Sources Anti Cancer Agents market size is expected to gain market growth in the forecast period of 2...

(Mar 20)

Market Overview The global Hydroxycamptothecin market size is expected to gain market growth in the forecast period of 2020 to 2025, ...

(Mar 20)

Market Overview The global Irinotecan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CA...

(Mar 20)

Market Overview The global Medical Protective Packaging market size is expected to gain market growth in the forecast period of 2020 ...

(Mar 20)

Market Overview The global Vinorelbine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a C...

GLOBAL TRAVELER'S DIARRHEA THERAPEUTICS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy